Kestra Medical Technologies (KMTS) Other Accumulated Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has reported Other Accumulated Expenses for 3 consecutive years, with $5.5 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Other Accumulated Expenses rose 54.67% year-over-year to $5.5 million; the TTM figure through Apr 2026 stood at $5.5 million (up 54.67% YoY), while the FY2026 annual figure was $5.5 million, up 54.67% from the prior year.
• Other Accumulated Expenses slipped to $5.5 million in Q2 2026 per KMTS's latest filing, from $6.1 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $6.1 million in Q1 2026 and bottomed at $1.2 million in Q2 2024.
• Historically, Other Accumulated Expenses has averaged $4.3 million across 3 years, with a median of $5.1 million in 2025.
• Annual changes were most pronounced in 2025 — Other Accumulated Expenses surged 197.82% — and 2026, when it soared 54.67%.
• Kestra Medical Technologies' Other Accumulated Expenses stood at $1.2 million in 2024, then soared by 348.87% to $5.3 million in 2025, then advanced by 2.62% to $5.5 million in 2026.
• Business Quant data shows KMTS's Other Accumulated Expenses at $5.5 million in Q2 2026, $6.1 million in Q1 2026, and $5.3 million in Q4 2025.